Macular edema refers to the swelling occurring in a specific area of the retina, which is the light-sensitive tissue located at the rear of the eye. Individuals experiencing macular edema often encounter blurred vision. This serious eye condition is a complication of diabetes. Avastin, Lucentis, Ozurdex, Iluvien, Vabysmo, and Eylea are some of the treatment options for diabetic macular edema.
As per a recent report by Expert Market Research, the diabetic macular edema market, covering the 8 major markets including the United States, United Kingdom, France, Germany, Italy, Spain, Japan, and India, was valued at $6.7 billion in 2023, and is poised to reach $10.4 billion by 2032.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com